ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy


 

HMGCLL1 Is a Predictive Germline Biomarker for Deep Molecular Response to Imatinib Therapy in Chronic Myeloid Leukemia

65 views
January 18, 2019
Comments 0
Login to view comments. Click here to Login